CRIS Current Research Information System

GIANNI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.565
NA - Nord America 737
EU - Europa 387
Continente sconosciuto - Info sul continente non disponibili 97
SA - Sud America 62
AF - Africa 40
OC - Oceania 3
Totale 2.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 702
VN - Vietnam 565
SG - Singapore 288
CN - Cina 268
IT - Italia 181
HK - Hong Kong 141
BD - Bangladesh 112
KR - Corea 68
FR - Francia 41
BR - Brasile 38
IN - India 31
DE - Germania 28
NL - Olanda 24
SE - Svezia 24
JP - Giappone 22
FI - Finlandia 20
CA - Canada 18
TH - Thailandia 14
CI - Costa d'Avorio 13
PH - Filippine 13
IE - Irlanda 12
AT - Austria 10
GB - Regno Unito 10
SC - Seychelles 10
RU - Federazione Russa 9
AR - Argentina 7
ID - Indonesia 7
GH - Ghana 6
MX - Messico 6
CH - Svizzera 5
JO - Giordania 5
CL - Cile 4
CR - Costa Rica 4
JM - Giamaica 4
LT - Lituania 4
TW - Taiwan 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
ES - Italia 3
IQ - Iraq 3
PK - Pakistan 3
RO - Romania 3
TG - Togo 3
ZA - Sudafrica 3
CO - Colombia 2
EC - Ecuador 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LC - Santa Lucia 1
MA - Marocco 1
MG - Madagascar 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
Totale 2.796
Salva come PNG Salva come JPEG
Città #
Singapore 217
Ho Chi Minh City 152
San Jose 149
Hanoi 137
Hong Kong 129
Hefei 118
Ashburn 77
Council Bluffs 74
Seoul 59
New York 43
Los Angeles 36
Santa Clara 34
Bologna 31
Lauterbourg 22
Da Nang 21
Haiphong 17
Beijing 14
Buffalo 14
Tokyo 14
Abidjan 13
Dublin 12
São Paulo 12
Bengaluru 11
Boardman 11
Ha Long 10
Helsinki 10
Hải Dương 10
Lappeenranta 10
Rome 10
Thái Nguyên 9
Amsterdam 8
Biên Hòa 8
Bắc Giang 8
Dallas 8
Milan 8
Frankfurt am Main 7
Accra 6
Bangkok 6
Princeton 6
Vienna 6
Can Tho 5
Casalecchio di Reno 5
Chandler 5
Charlotte 5
Des Moines 5
Hangzhou 5
Jakarta 5
Modena 5
Quận Bình Thạnh 5
San Lazzaro di Savena 5
Thái Bình 5
Điện Bàn 5
Amman 4
Castel Maggiore 4
Florence 4
Houston 4
Mexico City 4
Miami 4
Montreal 4
Philadelphia 4
Quận Phú Nhuận 4
Ravenna 4
Reggio Emilia 4
Southend 4
Toronto 4
Vũng Tàu 4
Atlanta 3
Baghdad 3
Bari 3
Bắc Ninh 3
Caracas 3
Chicago 3
Cleveland 3
Delhi 3
Freudenberg 3
Guangzhou 3
Hyderabad 3
La Paz 3
Lomé 3
Long Xuyen 3
Marseille 3
Monzuno 3
Munich 3
Nha Trang 3
Ninh Bình 3
Nuremberg 3
Paris 3
Pembroke 3
Phủ Lý 3
Quận Sáu 3
San Diego 3
Shanghai 3
Sofia 3
Tongling 3
Turin 3
Vinh 3
Waukesha 3
Zurich 3
Acalanes Ridge 2
Almaty 2
Totale 1.763
Salva come PNG Salva come JPEG
Nome #
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants 358
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 186
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 159
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 155
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 149
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 143
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) 133
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 103
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 97
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial 94
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 93
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 88
Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report 85
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors 79
Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-institutional study 66
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer 65
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 64
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 60
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer 56
Mapping breast cancer therapy with circulating tumor cells: The expert perspective 54
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 52
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 49
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study 41
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors 40
Circulating tumor DNA detection of local recurrence in a patient with early stage triple-negative breast cancer 39
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 35
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis 32
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine 32
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer 32
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer 31
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates 29
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer 26
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma 24
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 23
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all? 21
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review 19
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective study 18
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis 17
Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients 17
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer 16
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors 11
Totale 2.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 3 1 1 5 2 0 7 13 7
2022/202341 3 5 1 4 4 2 3 1 10 1 2 5
2023/202442 2 3 0 0 2 5 7 5 8 9 0 1
2024/2025293 17 22 24 24 24 15 7 12 9 21 33 85
2025/20262.237 321 139 95 80 70 26 323 113 517 207 183 163
2026/2027239 86 153 0 0 0 0 0 0 0 0 0 0
Totale 2.891